Clinical Rheumatology - Publications

Publications

(Where first/senior author is a member of Clinical Rheumatology group)

Glennon-Alty L, Hackett AP, Chapman EA, Wright HL. (2018) Neutrophils and redox stress in the pathogenesis of autoimmune disease. Free Radical Biology and Medicine doi: pii: S0891-5849(18)30159-X. doi: 10.1016/j.freeradbiomed.2018.03.049.


Lilleker JB, Diederichsen ACP, Jacobsen S, Guy M, Roberts ME, Sergeant JC, Cooper RG, Diederichsen LP, Chinoy H. Using Serum Troponins to Screen for Cardiac Involvement and Assess Disease Activity in the Idiopathic Inflammatory Myopathies. (2018) Rheumatology 2018


Zhao, S., Thong, D., Duffield, S. J., Hughes, D., & Goodson, N. J. (2018). Alcohol and disease activity in axial spondyloarthritis: a cross-sectional study. Rheumatology international. doi:10.1007/s00296-018-3927-2


Kochi Y, Kamatani Y, Kondo Y, Suzuki A, Kawakami E, Hiwa R, Momozawa Y, Fujimoto M, Jinnin M, Tanaka Y, Kanda T, Cooper RG…….Yamamoto K. Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis. Ann Rheum Dis 2018, 77: 602-611.


Lilleker JB, Vencovsky J, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, Oakley P, Benveniste O, Danieli MG, Danko K, Thuy NTP, Vazquez-Del Mercado M, Andersson H, Paepe B, de Bleecker JL, Maurer B, McCann LJ, Pipitone N, McHugh NJ, Betteridge ZE, New RP, Cooper RG, Ollier WE, Lamb JA, Steen Krogh N, Lundberg IE, Chinoy H, on behalf of all EuroMyositis contributors. The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis 2018, 77: 30-39.


Mitchell, T. S., Moots, R. J., & Wright, H. L. (2017). Janus kinase inhibitors prevent migration of rheumatoid arthritis neutrophils towards interleukin-8, but do not inhibit priming of the respiratory burst or reactive oxygen species production. Clinical and experimental immunology, 189(2), 250-258.


Wright, H. L., Makki, F. A., Moots, R. J., & Edwards, S. W. (2017). Low-density granulocytes: functionally distinct, immature neutrophils in rheumatoid arthritis with altered properties and defective TNF signalling. Journal of leukocyte biology, 101(2), 599-611.


Wright, H. L., Cox, T., Moots, R. J., & Edwards, S. W. (2017). Neutrophil biomarkers predict response to therapy with tumor necrosis factor inhibitors in rheumatoid arthritis. Journal of leukocyte biology, 101(3), 785-795.


Rider LG, Aggrawal, R, Pistorio A, Erman B, Bayat N, Erman B, , Feldman BM, Huber AM, Hansen P, Oddis CV, Lundberg IE, Amato AA, Chinoy H, Cooper RG…… and the International Myositis Assessment and Clinical Studies Group. 2016 ACR/EULAR criteria for minimal, moderate and major clinical response in juvenile dermatomyositis. (2017) Arth Rheum 69: 911-923


Nair, J. R., & Moots, R. J. (2017). Behcet's disease. Clinical medicine, 17(1), 71-77.


Bottai M, Tjärnlund A, Santoni G, Werth VP, Pilkington C, de Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, …… Lundberg IE. The International Myositis Classification Criteria Project consortium, the Euromyositis register and the Juvenile Dermatomyositis Cohort Biomarker Study and Repository (JDRG) (UK and Ireland). EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report. (2017) RMD Open 3:e000507. Doi:10.1136/rmdopen-2017-000507.


Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, …….and the International Myositis Classification Criteria Project Consortium, the Euromyositis Register, and the Juvenile Dermatomyositis Cohort Biomarker Study and Repository (UK and Ireland). 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups. (2017) Ann Rheum Dis 76: 1955-1964.


Rider LG, Ruperto N, Pistorio A, Erman B, Bayat N, Lachenbruch PA, Rockette H, Feldman BM, Huber AM, Hansen P, Oddis CV, Lundberg IE, Amato AA, Chinoy H, Cooper RG, ……..and the International Myositis Assessment and Clinical studies Group and the Paediatric Rheumatology International Trials Organisation. 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria – methodological aspects. (2017) Rheumatology 56: 1884-1893.


Lilleker JB, Gordon P, Lamb JA, Lempp H, Cooper RG, Roberts ME, Jordan P, Chinoy H. Patient-centred standards of care for adults with myositis. BMC Rheumatology 2017 (DOI 10.1186/s41927-017-0002-7).


Aggarwal R, Rider LG, Ruperto N, Bayat N, Erman B, Feldman BM, Oddis CV, Amato AA, Chinoy H, Cooper RG, ……. for the International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. (2017) Arth Rheum 69: 898-910.


Zhao, S., Nair, J. R., & Moots, R. J. (2017). Biosimilars: From extrapolation into off label use.. Current pharmaceutical design. doi:10.2174/1381612824666171129193258


Zhao, S., Otieno, F., Akpan, A., & Moots, R. J. (2017). Complementary and Alternative Medicine Use in Rheumatoid Arthritis: Considerations for the Pharmacological Management of Elderly Patients. Drugs & aging, 34(4), 255-264.


Lilleker JB, Rietveld A, Pye SR, Mariampillai K, Benveniste O, Peeters MTJ, Miller JAL, Hanna MG, Machado PM, Parton MJ, Gheorghe KR, Badrising UA, Lundberg IE, Sacconi S, Herbert MK, McHugh NJ, Lecky BRF, Brierley C, Hilton-Jones D, Lamb JA, Roberts ME, Cooper RG, Saris CGJ, Pruijn GJM, Chinoy H, van Engelen BGM. Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis. (2017) Ann Rheum Dis 76:862-868.


Aggarwal R, Rider LG, Ruperto N, Bayat N, Erman B, Feldman BM, Oddis CV, Amato AA, Chinoy H, Cooper RG, Dastmalchi M, Fiorentino D, Isenberg D, Katz JD, Mammen A, de Visser M, Ytterberg SR, Lundberg IE, Chung L, Danko K, García-De La Torre I, Wook YW, Villa L, Rinaldi M, Rockette H, Lachenbruch PA, Miller FW, Vencovsky J, for the International Myositis Assessment and Clinical Studies Group and the Paediatric Rheumatology International Trials Organisation
2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. (2017) Ann Rheum Dis 76: 792-801


Rothwell S, Cooper RG, Lundberg IE, Gregersen PK, Hanna MG, Machado PM, Herbert MK, Pruijn GJM, Lilleker JB, Roberts M, Bowes J, Seldin MF, Vencovsky J, Danko K, Limaye V, Selva-O'Callaghan A, Platt H, Molberg Ø, Benveniste O, Radstake TRDJ, Doria A, Bleecker Jan D, Paepe BD, Gieger C, Meitinger T, Winkelmann J, Amos CI, Ollier WER, Padyukov L, Lee AT, Lamb JA, Chinoy H. Immune-array analysis in sporadic inclusion body myositis reveals HLA-DRB1 amino acid heterogeneity across the myositis spectrum. (2017) Arth Rheum 69: 1090-1099.


Cotton CV, Spencer LG, New RP, Cooper RG. Interstitial lung disease (ILD): Reviewing the utility of comprehensive autoantibody testing to differentiate CTD associated and idiopathic ILD subgroup cases. Rheumatology 2017, 56: 1264-1271.


Zhao, S., Challoner, B., Khattak, M., Moots, R. J., & Goodson, N. J. (2017). Increasing smoking intensity is associated with increased disease activity in axial spondyloarthritis. Rheumatology international, 37(2), 239-244. doi:10.1007/s00296-016-3590-4


Moots, R. J., Fortune, F., & Situnayake, D. (2017). The Behçet's centres of excellence: A new paradigm for care delivery in complex diseases. Rheumatology. doi:10.1093/rheumatology/kex037


Moots, R. J., Sebba, A., Rigby, W., Ostor, A., Porter-Brown, B., Donaldson, F., . . . Genovese, M. C. (2017). Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials. Rheumatology, 56(4), 541-549.


Moots, R. J., Xavier, R. M., Mok, C. C., Rahman, M. U., Tsai, W. -C., Al-Maini, M. H., . . . Vlahos, B. (2017). The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study (vol 12, e0175207, 2017). PLoS ONE, 12(6). doi:10.1371/journal.pone.0179308


Zhao, S., Challoner, B., Khattak, M., Moots, R. J., & Goodson, N. J. (2017). Increasing smoking intensity is associated with increased disease activity in axial spondyloarthritis. Rheumatology international, 37(2), 239-244. doi:10.1007/s00296-016-3590-4


Zhao S, Challoner B, Khattak M, Moots RJ, Goodson NJ. (2017) Increasing smoking intensity is associated with increased disease activity in axial spondyloarthritis. Rheumatol Int. 37(2): 239–244


Zhao, S., Thong, D., Duffield, S., & Goodson, N. (2017). Vitamin D Deficiency in Axial Spondyloarthritis is Associated With Higher Disease Activity. Archives of rheumatology, 32(3), 209-215.


Fok, M., Bashir, M., Goodson, N., Oo, A., & Moots, R. (2017). Thoracic aortic aneurysms in Behçet's disease.. Rheumatology 56(4), 501-502.


Chinoy H, Cooper RG (2017) Oxford Handbook of Myositis, Oxford Press


Thieblemont, N., Wright, H. L., Edwards, S. W., & Witko-Sarsat, V. (2016). Human neutrophils in auto-immunity. Seminars in immunology, 28(2), 159-173.


Holden, S. E., Currie, C. J., Lennon, M., Reynolds, A. V., & Moots, R. J. (2016). Cost of dose escalation in people with rheumatoid arthritis treated with tumour necrosis factor inhibitors across Europe. Clinical and experimental rheumatology, 34(4), 679-684.


Lightfoot AP, Cooper RG. The role of myokines in muscle health and disease. Curr Opin Rheum 2016, 28: 661-666 (doi: 10.1097/BOR.0337).


Ahmed AE, Lowe D, Kirton JA, O'Brien MR, Mediana A, Frankland H, Bruce H, Kennedy T, Rogers SN, Moots RJ. (2016). Development of a Rheumatology-specific Patient Concerns Inventory and Its Use in the Rheumatology Outpatient Clinic Setting. Journal of rheumatology, 43(4), 779-787.


Moots, R. J., Balsa, A., & Wolbink, G. (2016). Reporting of potential immunogenicity with biologic drugs: clarity and accuracy required. Annals of the rheumatic diseases, 75(5), E24.


Lightfoot AP, Cooper RG. Endurance exercise: An important therapeutic adjuvant in the overall treatment of myositis? (2016) Arth Rheum, 68: 1578-1581.


Parkes JE, Rothwell S, Day PJ, McHugh NJ, Betteridge ZE, Cooper RG, Ollier WE, Chinoy H, Lamb JA. Protein-protein interaction and pathway analyses in the idiopathic inflammatory myopathies (2016) Arth Res Ther 18(1): 156.


Herbert MK, Stammen-Vogelzangs J, Verbeek MM, Rietveld M, Lundberg IE, Chinoy H, Lamb JA, Cooper RG, Roberts M, Badrising UA, De Bleecker JL, Machado PM, Hanna MG, Plestilova L, Vencovsky J, van Engelen BG, Pruijn GJM. Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases. Ann Rheum Dis 2016, 75: 696-701. (DOI: 10.1136/annrheumdis-2014-206691).


Rothwell S, Cooper RG, Lundberg IE, Miller FW, Gregersen PK, Bowes J, Vencovsky J, Danko K, Limaye V, Selva O'Callaghan A, Hanna MG,0 Machado P, Pachman LM, Reed AM, Rider LG, Cobb J,13 Platt H,14 Molberg O, Benveniste O, Mathiesen P, Radstake TR, Doria A, De Bleecker J, De Paepe B, Maurer B, Ollier WE, Padyukov L, O'Hanlon TP, Lee A, Amos CI, Wedderburn LR, Chinoy H, Lamb JA, and the Myositis Genetics Consortium. Dense Genotyping of Immune-Related Loci in the Idiopathic Inflammatory Myopathies Confirms HLA alleles as Strongest Genetic Risk Factor and Suggests Different Genetic Background for Major Clinical Subgroups. (2016) Ann Rheumatic Dis 75: 1558-1566


Lightfoot AP, Cooper RG. Endurance exercise: An important therapeutic adjuvant in the overall treatment of myositis? (2016) Arth Rheum 68: 1578-1581


Bradley WJ, Morehen JC, Haigh J, Clarke JS, Donovan TF, Twist C, Cotton C, Shepherd S, Cocks MS, Sharma AK, Impey SG, Cooper RG, MacLaren DP, Morton JP, Close GL. Muscle glycogen utilisation during rugby match play: effects of pre-game carbohydrate. (2016) J Sci Med Sport 19: 1033-1038.


Zhao, S., Hauser, B., Visconti, M. R., Riches, P. L., Ralston, S. H., & Goodson, N. J. (2016). Autoantibodies to osteoprotegerin and bone mineral density in axial spondyloarthritis. Rheumatology Vol. 55 (pp. 143).


Palmer, K. T., & Goodson, N. (2015). Ageing, musculoskeletal health and work. Best Practice & Research Clinical Rheumatology, 29(3), 391-404.


Tuntirungrojchai, P., Chan, M., Sparks, C., & Goodson, N. J. (2015). Chronic kidney disease and methotrexate prescribing in an inflammatory arthritis population. Rheumatology Vol. 54 (pp. 192).


Zhao, S., & Goodson, N. J. (2015). Diffuse idiopathic skeletal hyperostosis and isotretinoin in cystic acne. BMJ case reports, 2015. doi: 10.1136/bcr-2015-209775


Miller FW, Chen W, O'Hanlon TP, Cooper RG, Vencovsky J, Rider LG, Danko K, Wedderburn LR, Lundberg IE, Pachman LM, Reed AM, Ytterberg SR, Padyukov L, Selva-O'Callaghan A, Radstake TR, Isenberg DA, Chinoy H, Ollier WER, Scheet P, Peng B, Lee A, Byun J, Lamb JA, Gregersen PK, Amos CI with the Myositis Genetic Consortium. Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes. (2015) Genes and Immunity, 16: 470-480


Owens DJ, Sharples AP,1 Polydorou I,Alwan N,Donovan T, Tang J, Fraser D, Cooper RG, Morton JP, Stewart C, Close GL. A systems-based investigation into vitamin D and skeletal muscle repair, regeneration, and hypertrophy. (2015) Am J Physiol Endocrinol Metab 309: E1019–E1031


Abdullah, A., Sparks, C., Zhao, S., Estrach, C., & Goodson, N. J. (2015). Self-reported comorbidity burden correlates with functional disability and disease activity in early rheumatoid arthritis. Rheumatology, 54, 59.


Chinoy H, Cooper RG. Exploring new mechanisms of weakness-induction n myositis, further dissection of clinical phenotypes and identification of new biomarkers in the idiopathic inflammatory myopathies. (2015) Curr Opin Rheum 27: 577-579.


Lightfoot AP, Nagaraju K, McArdle A, Cooper RG. Understanding the origin of non-immune cell-mediated weakness in the idiopathic inflammatory myopathies (IIM) – Potential role of ER stress-pathways. (2015) Curr Opin Rheum 27: 580-585.


Seetho, I. W., Parker, R. J., Craig, S., Duffy, N., Hardy, K. J., Wilding, J. P. H., & Goodson, N. J. (2015). Serum urate and obstructive sleep apnoea in severe obesity. Chronic respiratory disease, 12(3), 238-246.


Seetho, I. W., Parker, R. J., Craig, S., Duffy, N., Hardy, K. J., Wilding, J. P., & Goodson, N. J. (2015). Serum urate and obstructive sleep apnoea in severe obesity. Chronic Respiratory Disease, 12(3), 238-246.


Zhao, S., & Goodson, N. J. (2015). Smoking and comorbidities in rheumatoid arthritis: what we know and what we can do?. International Journal of Clinical Rheumatology, 10(1), 45-53.


Zhao, S., Gardner, K., Taylor, W., Marks, E., & Goodson, N. (2015). Vitamin D assessment in primary care: changing patterns of testing.. London journal of primary care, 7(2), 15-22.


Moots, R. J., Mays, R., Stephens, J., & Tarallo, M. (2015). Burden of dose escalation with tumour necrosis factor inhibitors in rheumatoid arthritis: a systematic review of frequency and costs. Clinical and experimental rheumatology, 33(5), 737-745.


Felis-Giemza, A., & Moots, R. J. (2015). Measurement of anti-drug antibodies to biologic drugs. A sexy trend-or is it clinically meaningful? Rheumatology, 54(11), 1941-1943. doi:10.1093/rheumatology/kev279


Moots, R. J., & Felis-Giemza, A. (2015). Motherhood and fatherhood of patients with inflammatory rheumatic diseases in the era of biologics. Where are we after 20 years of anti-TNFs’ use? Reumatologia/Rheumatology, 5, 233-235. doi:10.5114/reum.2015.55823


Wright, H. L., Thomas, H. B., Moots, R. J., & Edwards, S. W. (2015). Interferon gene expression signature in rheumatoid arthritis neutrophils correlates with a good response to TNFi therapy. Rheumatology, 54(1), 188-193. doi:10.1093/rheumatology/keu299


Wright, H. L., Mewar, D., Bucknall, R. C., Edwards, S. W., & Moots, R. J. (2015). Synovial fluid IL-6 concentrations associated with positive response to tocilizumab in an RA patient with failed response to anti-TNF and rituximab. Rheumatology, 54(4), 743-744.


Iaccarino L Cooper RG, Doria A. Polymyositis and dermatomyositis. (2015) In Eds: Bijlsma JMJ, Da Silva JAP, Hachulla E, Doherty M, Cope A, Liote F - EULAR Textbook on Rheumatic Diseases. London: BMJ Publishing Group Ltd, Chapter 24: 636-666.


Chinoy H, Cooper RG. Polymyositis and dermatomyosityis. (2015) In Eds: Watts R, Conagham P, Denton C, Foster H, Isaacs J, Muller-Ladner U. – Oxford Textbook of Rheumatology (6th Edition)


Zhao, S., Duffield, S. J., Moots, R. J., & Goodson, N. J. (2014). Systematic review of association between vitamin D levels and susceptibility and disease activity of ankylosing spondylitis. Rheumatology, 53(9), 1595-1603.


Wright, H. L., Cross, A. L., Edwards, S. W., & Moots, R. J. (2014). Effect of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo. Rheumatology 53(7) 1321-31


Alfirevic A, Neely D, Armitage J, Chinoy H, Cooper RG, Laaksonen R, Carr D, Bloch K, Fahy J, Hanson A, Yue Q-Y, Wadelius M, Maitland-van der Zee A-H, Voora D, Psaty D, Palmer C, Pirmohamed M. Phenotype standardisation for statin-induced myotoxicity. (2014) Clin Pharmacol Ther 96: 470-476


Jani M, Massey J, Wedderburn LR, Vencovsky J, Danko K, Lundberg IE, Padyukov L, Selva-O'Callaghan A, Radstake T, Platt H, Warren RB, Griffiths CE, Lee A, Gregersen PK, Miller FM, Ollier WE, Cooper RG, Chinoy H, Lamb JA. Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathies. (2014) Ann Rheum Dis 73: 1750-1752.


Wright, H. L., Moots, R. J., & Edwards, S. W. (2014). The multifactorial role of neutrophils in rheumatoid arthritis. Nature reviews rheumatology, 10(10), 593-601.


Chinoy H, Cooper RG. Polymyositis and dermatomyositis. In Eds: Watts R, Conaghan P, Denton C, Foster H, Isaacs J, Muller-Ladner U. (2014) Oxford Textbook of Rheumatology (5th Edition), Chapter 24: 1009-1032.


Cooper RG, Chinoy H, Lundberg IE. (2014) Gene-gene and gene-environment interactions in defining risk and spectrum of phenotypes in idiopathic inflammatory myopathies. In Eds: Padyukov L. Between the Lines of the Genetic Code: Genetic Interactions in Understanding Disease and Complex Phenotypes. Elsevier. Chapter 7: 115-132.